NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

膿毒症管理分析第一部分:診斷

Analysing Sepsis Management Part I: Diagnosis

出版商 Frost & Sullivan 商品編碼 949173
出版日期 內容資訊 英文 48 Pages
商品交期: 最快1-2個工作天內
價格
膿毒症管理分析第一部分:診斷 Analysing Sepsis Management Part I: Diagnosis
出版日期: 2020年06月22日內容資訊: 英文 48 Pages
簡介

本報告探討敗血症管理分析中的診斷方法,並認識到敗血症認識,流行病學,敗血症診斷,快速敗血症診斷的潛在臨床需求以及現有和正在發展的敗血症管理。它提供有關診斷平台,專利概況,臨床研究,區域分析,北美,歐洲和一些亞洲市場參與者的信息。

內容

第1章執行摘要

  • 調查範圍:敗血症的診斷
  • 分析框架:Frost&Sullivan核心價值
  • 調查方法:成功的五個步驟
  • 促進敗血症診斷的技術創新的重大發現

第2章技術快照

  • 研究範圍:敗血症診斷的現狀和問題
  • 敗血症診斷測試□□的類型

第3章膿毒症的認識

  • 敗血症的基礎知識和流行病學
  • 敗血症管理中的潛在需求

第4章臨床試驗和敗血症診斷的專利情況

  • 敗血症診斷的臨床試驗展望
  • 工業界開展的敗血症診斷測試□□臨床試驗
  • 非行業贊助的歐洲敗血症診斷測試□□臨床試驗
  • 在美洲,亞洲和其他地方的非工業支持的敗血症診斷測試□□的臨床試驗
  • 包含敗血症專利的學術出版物

第5章敗血症的快速診斷

  • 敗血症診斷公司列表
  • 美國的敗血症診斷
  • 基於降鈣素的敗血症診斷
  • 降鈣素和基於組合的敗血症診斷技術
  • 通過多種新的免疫分析方法對敗血症的診斷
  • 基於序列的病原體敗血症檢測 AI測序平台,用於敗血症引起病原體檢測
  • 基於機器學習/宿主基因表達的敗血症診斷平台
  • 基於質譜的敗血症診斷平台
  • 敗血症診斷的新平台
  • 用於膿毒症診斷的分析裝置/裝置
  • 歐洲:基於PCR的敗血症診斷平台
  • 美洲:基於PCR的敗血症診斷平台,適用於大型企業
  • 美洲:面向中型公司的基於PCR的敗血症診斷平台
  • 美洲:基於PCR的中小企業敗血症診斷平台
  • 亞洲:基於PCR的敗血症診斷平台
  • 正在開發的敗血症診斷測試
  • 具有盈利能力的化糞池診斷公司

第6章增長機會和建議

  • 增長機會1:為您的特定需求選擇最佳測試
  • 增長機會2:診斷後的商機

第7章主要行業影響者

  • 行業互動
  • 免責聲明
目錄
Product Code: D995

Recent Advances in Sepsis Diagnosis: PCR, Immunoassays, Sequencing and beyond

The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms.

The clinical studies part covers major sepsis diagnosis clinical trials from clinicaltrials.gov, their progress status, type of phase and industrial and non-industrial sponsors.

The sepsis diagnosis platforms discussed in this research study include existing and developing sepsis diagnostic platforms such as procalcitonin immunoassays, lateral flow immunoassays, Heparin Binding Protein (HBP) immunoassays, Complement C5a based immunoassays; nucleic acid sequencing directly from body fluids and identification of pathogens and/or antimicrobial profiling through Artificial Intelligence (AI) based technology; Novel technologies like blood cleaning system, Cell Mechanics, FISH (Fluorescence In-Situ Hybridization), Host-gene-expression-based approaches for sepsis diagnosis.

A major part of the study talks about a variety of PCR and real-time PCR-based rapid diagnosis platforms for sepsis management. Some of these are direct sample-in/results-out and some platforms require few hours of blood incubation followed by sample-in/results-out.

Additionally, this study discusses some of the instruments/ analysers and handheld devices, Mass-spectroscopy based sepsis diagnosis, Machine Learning and predictive algorithm for sepsis diagnosis and combination approaches.

Further, this study profiles major players in sepsis diagnosis from North America, Europe and some players from Asia.

Table of Contents

1.0 Executive Summary

  • 1.1. Research Scope: Sepsis Diagnosis
  • 1.2. Analysis Framework: Frost & Sullivan Core Value
  • 1.3. Research Methodology: Five Steps Toward Success
  • 1.4. Key Findings of Technology Breakthrough Driving Sepsis Diagnosis

2.0 Technology Snapshot

  • 2.1. Research Scope: Current Status and Challenges of Sepsis Diagnosis
  • 2.2. Types of Sepsis Diagnosis Tests

3.0 Understanding Sepsis

  • 3.1. Fundamentals and Epidemiology of Sepsis
  • 3.2 Unmet Needs in Sepsis Management

4.0 Clinical Trials and Patent Landscape for Sepsis Diagnosis

  • 4.1. Outlook of Sepsis Diagnosis Clinical Trials
  • 4.2. Industry Sponsored Sepsis-Diagnostic Test Clinical Trials
  • 4.3. Non-industry Sponsored Sepsis-Diagnostic Test Clinical Trials in Europe
  • 4.4. Non-industry Sponsored Sepsis-Diagnostic Test Clinical Trials in the Americas, Asia and Rest of the World
  • 4.5. Scholarly Publications Including Patents for Sepsis

5.0 Rapid Diagnosis of Sepsis

  • 5.1. List of COMPANIES in Sepsis Diagnosis
  • 5.2. The US Is The Biggest Hub For Sepsis Diagnosis
  • 5.3. Procalcitonin-based Sepsis Diagnosis
  • 5.4. Procalcitonin and Combination-based Sepsis Diagnosis Technologies
  • 5.5. Sepsis Diagnosis Through Multiple Novel Immunoassays
  • 5.6. Sequencing-based Detection of Sepsis Causing Pathogens
  • 5.7. AI-Sequencing Platforms for Sepsis Causing Pathogen Detection
  • 5.8. Machine Learning AND Host gene expression-based Platforms for sepsis diagnosis
  • 5.9. Mass Spectroscopy-based Sepsis Diagnosis Platforms
  • 5.10. Novel Platforms for Sepsis Diagnosis
  • 5.11. Analyzers and Devices for Sepsis Diagnosis
  • 5.12. Europe: PCR-based Sepsis Diagnosis Platforms
  • 5.13. Americas: PCR-based Sepsis Diagnosis Platforms from big Companies
  • 5.14. Americas: PCR-based Sepsis Diagnosis Platforms from mid-sized Companies
  • 5.15. Americas: PCR-based Sepsis Diagnosis Platforms from small Companies
  • 5.16. Asia: PCR-based Sepsis Diagnosis Platforms
  • 5.17. Sepsis Diagnosis Tests under Development
  • 5.18. Sepsis Diagnosis Companies with Revenue

6.0 Growth Opportunities and Companies to Action

  • 6.1. Growth Opportunity 1: Selecting the Perfect Test for Specific Need
  • 6.2. Growth Opportunity 2: Business Opportunities Beyond Diagnosis

7.0 Key Industry Influencers

  • 7.1. Industry Interactions
  • Legal Disclaimer